Abstract
This paper considers whether assisted suicide and euthanasia (AS/E) is an area for medical regulation or whether there is a better alternative regulatory mechanism to govern it. Drawing from empirical evidence across a range of jurisdictions where it is legalized, the paper argues that there are at least four good reasons to consider demedicalizing AS/E: 1) pragmatic ethical issues of infrastructural weakness in AS/E service provision in already overstretched healthcare systems globally; 2) challenges of medicalization; 3) regulatory complexities concerning medical law (including pharmaceutical law) and criminal law; 4) the risk that AS/E becomes more easily susceptible to healthcare economics. The paper suggests several recommendations concerning a possible ‘demedicalized model.’
| Original language | English |
|---|---|
| Journal | Journal of Law, Medicine and Ethics |
| Publication status | Published - 28 May 2025 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
-
SDG 16 Peace, Justice and Strong Institutions
Keywords
- Assisted dying
- Medicalisation
- Pharmaceuticalisation
Fingerprint
Dive into the research topics of 'Is assisted dying really a matter for medical regulation?'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver